Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018
Canadian Journal of Cardiology2018Vol. 34(12), pp. 1553–1563
Citations Over TimeTop 1% of 2018 papers
Liam R. Brunham, Isabelle L. Ruel, Sumayah Aljenedil, Jean‐Baptiste Rivière, Alexis Baass, Jack V. Tu, G.B. John Mancini, Paolo Raggi, Milan Gupta, Patrick Couture, Glen J. Pearson, Jean Bergeron, Gordon A. Francis, Brian W. McCrindle, Katherine M. Morrison, Julie St‐Pierre, Mélanie Henderson, Robert A. Hegele, Jacques Genest, Jeannette Goguen, Daniel Gaudet, Guillaume Paré, Jacques Romney, Thomas Ransom, Sophie Bernard, Pamela Katz, Tisha Joy, David Bewick, James M. Brophy
Related Papers
- → PCSK9 inhibition in patients with hypercholesterolemia(2015)28 cited
- → Trial evaluating evolocumab, a pcsk9 antibody, in patients with homozygous fh (tesla): Results of the randomized, double-blind, placebo-controlled trial(2014)15 cited
- → Anti-PCSK9 Antibodies: A New Era in the Treatment of Dyslipidemia(2017)8 cited
- → A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 Studies(2020)8 cited
- → The efficacy of anti-PCSK9 antibodies: Results from recent trials(2017)10 cited